GlassScriptPhysician profile
Bradley Frasier
NPI 1013932045
$13,532.29
in general payments reported to CMS, 2019-2025
55 companies · $1,873 in 2025
The $1,873 reported for 2025 was more than what 93% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,770 · 2020: $1,428 · 2021: $2,454 · 2022: $1,705 · 2023: $1,958 · 2024: $2,344 · 2025: $1,873.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,926 · Education: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,925.66 |
| Education | $249.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,772.92 | 2019-2025 | Erleada, Rybrevant, Carvykti |
| Astellas Pharma US INC | $1,765.64 | 2019-2025 | Xtandi, Myrbetriq, Veozah |
| Dendreon Pharmaceuticals LLC | $1,489.19 | 2019-2025 | Provenge |
| Abbvie INC. | $917.47 | 2019-2025 | |
| Allergan, INC. | $620.97 | 2019-2021 | |
| Biotissue Holdings INC. | $518.36 | 2024-2025 | |
| Coloplast Corp | $478.27 | 2019-2024 | Speedicath, Saffron |
| Pfizer INC. | $454.24 | 2019-2025 | |
| Myriad Genetic Laboratories, INC. | $451.96 | 2021-2025 | Prolaris, Myrisk |
| Urogen Pharma, INC. | $404.39 | 2020-2025 | Jelmyto |
| Bayer Healthcare Pharmaceuticals INC. | $400.11 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $340.14 | 2019-2024 | Xiaflex |
| Myovant Sciences INC. | $314.01 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $290.85 | 2021-2025 | Pylarify |
| Blue Earth Diagnostics | $248.54 | 2019-2025 | Posluma |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $243.35 | 2020-2025 | |
| Sumitomo Pharma America, INC. | $200.87 | 2023-2025 | Orgovyx, Gemtesa |
| Amgen INC. | $192.72 | 2019-2021 | |
| Accord Healthcare, INC. | $184.60 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $169.90 | 2020-2025 | Keytruda, Lynparza, Welireg |
| Olympus America INC. | $167.46 | 2019-2024 | Itind System |
| Procept Biorobotics Corporation | $154.36 | 2023-2025 | Aquabeam Robotic System, Aquabeam System |
| Ferring Pharmaceuticals INC. | $137.94 | 2019-2025 | Adstiladrin |
| Intuitive Surgical, INC. | $132.05 | 2024 | |
| Novartis Pharmaceuticals Corporation | $128.06 | 2022-2024 | |
| Acerus Pharmaceuticals Corporation | $124.65 | 2020-2022 | |
| Immunitybio, INC. | $114.11 | 2024-2025 | |
| Telix Pharmaceuticals | $101.32 | 2023-2024 | Illuccix |
| Hollister Incorporated | $100.91 | 2019-2022 | |
| Teleflex LLC | $91.03 | 2021-2024 | Urolift |
| 180 Medical, INC. | $85.05 | 2019-2023 | Gentlecath Glide |
| Alnylam Pharmaceuticals INC. | $70.76 | 2021-2023 | Oxlumo |
| Urovant Sciences INC | $65.30 | 2021-2022 | |
| C. R. Bard, INC. & Subsidiaries | $65.21 | 2023-2024 | Bard Urinary Drainage Bag |
| Foundation Medicine, INC. | $60.66 | 2019-2023 | |
| Abc Home Medical Supply, INC. | $59.79 | 2022 | |
| Sagent Pharmaceuticals | $45.13 | 2020-2022 | |
| Duchesnay USA Incorporated | $33.49 | 2019 | |
| Palette Life Sciences, INC. | $32.00 | 2022 | |
| Boston Scientific Corporation | $28.12 | 2022-2025 | Watchman Flx |
| Tempus Ai, INC | $25.11 | 2024 | |
| Caris Mpi, INC. | $22.30 | 2025 | Mi Cancer Seek |
| Innovation Technologies INC | $21.63 | 2022 | |
| Metuchen Pharmaceuticals | $20.99 | 2019 | |
| Sun Pharmaceutical Industries INC. | $19.82 | 2022 | |
| Davol INC. | $19.42 | 2020 | |
| Ethicon US, LLC | $18.75 | 2024 | Ethicon, Vistaseal, Enseal X1 |
| Axonics, INC. | $18.46 | 2023 | Axonics |
| Endo USA, INC. | $18.20 | 2025 | Xiaflex |
| Convatec INC. | $17.14 | 2022 | |
| Avadel Specialty Pharmaceuticals, LLC | $16.52 | 2019 | |
| Antares Pharma, INC. | $15.57 | 2022 | |
| Organogenesis INC. | $14.97 | 2025 | Puraply Wound Matrix |
| Photocure INC | $14.24 | 2025 | Cysview |
| Halozyme INC | $13.27 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Frasier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.